Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Top 100 Drugs

Top 200 by sales

Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon

Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone

Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec

More A-K · More L-Z · By Class · UK Medicines

For Consumers

For Professionals

For Researchers

Announcements

Physician's Desk Reference (PDR)

Latest FDA New Drug Approvals

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.

Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and ...

Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an ...

More...

Drugs in Development – Not yet approved

linaclotide
Linaclotide is a guanylate cyclase type-C (GC-C) agonist in development for the treatment of irritable bowel syndrome with constipation ...

pertuzumab
Pertuzumab is a humanized monoclonal antibody being studied in early and advanced stages of HER2-positive breast cancer and advanced ...

crofelemer
Crofelemer is a proanthocyanidin oligomer in development for the treatment of secretory diarrhea, including HIV-associated diarrhea, ...

More...

Daily Medical News

RSS

Smoking May Up Cancer Risk in Barrett's Esophagus Patients

FRIDAY, Feb. 10 -- People with the condition called Barrett's esophagus who are smokers may have double the risk of developing esophageal cancer, a new study warns. These people also have twice the risk of developing advanced precancerous cells, according to the study in the February issue of Gastroenterology. "We found that tobacco smoking emerged as the strongest lifestyle risk factor for...

Most Teens Who Self-Harm Are Not Evaluated for Mental Health in ER

FRIDAY, Feb. 10 -- Most children and teens who deliberately injure themselves are discharged from emergency rooms without an evaluation of their mental health, a new study shows. The findings are worrisome since risk for suicide is greatest right after an episode of deliberate self-harm, according to researchers at Nationwide Children's Hospital in Columbus, Ohio. The researchers also found the...

Brain Scans May Predict How People Learn

FRIDAY, Feb. 10 -- Researchers report that brain scans can help predict how people will perform a challenging mental task, a discovery that could lead to a better understanding of how the mind learns new things. The researchers found that what they once thought was "noise" in the brain, like static from a television, actually plays a major role and "is very important for understanding how the...

More...

Latest Pharma Industry News

RSS

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

ST. LOUIS, Feb. 9, 2012 /PRNewswire/ -- Mobius Therapeutics, LLC, a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform product, Mitosol. This initial indication is for the use of Mitosol in glaucoma surgery. With FDA approval, Mobius Therapeutics can start marketing and production efforts for Mitosol immediately. "The...

Sanofi Announces FDA Approval of Sklice Lotion for the Treatment of Head Lice

BRIDGEWATER, N.J., Feb. 7, 2012 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without...

Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 8, 2012 - Ironwood Pharmaceuticals, Inc. announced that it was informed this evening that the U.S. Food and Drug Administration (FDA) will not schedule an advisory committee meeting in connection with the its review of the New Drug Application (NDA) for linaclotide proposed for the treatment of irritable bowel syndrome with constipation (IBS-C) and...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Mitosol, Sklice, Jentadueto, Kalydeco, Voraxaze, Erivedge, Bydureon, Inlyta, Picato, Zetonna ...also see new filings.

Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch

Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...

Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store

1st June, 2011 – We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more ...

Pill Identifier Update

We’ve updated our pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest an ...

See more blog posts or follow us on twitter.

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search: